1. Home
  2. AXP vs MRK Comparison

AXP vs MRK Comparison

Compare AXP & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Express Company

AXP

American Express Company

HOLD

Current Price

$383.83

Market Cap

255.1B

Sector

Finance

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$106.64

Market Cap

260.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXP
MRK
Founded
1850
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.1B
260.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AXP
MRK
Price
$383.83
$106.64
Analyst Decision
Buy
Buy
Analyst Count
22
15
Target Price
$329.95
$111.93
AVG Volume (30 Days)
2.5M
15.7M
Earning Date
01-30-2026
02-03-2026
Dividend Yield
0.86%
3.24%
EPS Growth
9.59
58.08
EPS
14.88
7.56
Revenue
$65,294,000,000.00
$64,235,000,000.00
Revenue This Year
$19.86
$1.97
Revenue Next Year
$8.91
$4.96
P/E Ratio
$25.69
$13.90
Revenue Growth
10.22
1.68
52 Week Low
$220.43
$73.31
52 Week High
$387.49
$105.84

Technical Indicators

Market Signals
Indicator
AXP
MRK
Relative Strength Index (RSI) 63.82 70.45
Support Level $372.77 $96.79
Resistance Level $387.49 $100.94
Average True Range (ATR) 7.27 2.47
MACD 0.23 0.24
Stochastic Oscillator 83.22 95.96

Price Performance

Historical Comparison
AXP
MRK

About AXP American Express Company

American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. It operates in four segments: US consumer services, US commercial services, international card services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: